Quicklinks
Sickle Cell
Sickle cell anemia is an inherited disorder that, while manageable, at this time has no cure and can severely and painfully affect the life and health of an afflicted child or adult. 1 in 12 African Americans and 1 in 172 Hispanic Americans is a carrier.
It is now in our power to prevent sickle cell anemia by DNA testing and education.
Genetic testing has already displayed a remarkable success in reducing the number of children born with some genetic diseases, such as Tay Sachs in Jewish populations (90% reduction in children born with the disease in 35 years). This shows that knowledge is power and when used correctly, this power can have tremendous results. A simple genetic test can determine whether each parent (or young adult prior to becoming a parent) is a carrier for sickle cell anemia, helping them to make an informed decision about parenting children and the risk that their child will inherit the disorder. With this knowledge, parents will have the power to prevent sickle cell anemia from afflicting the next generation.
So what can YOU do to help?
- Ensure that your children and grandchildren, prior to marriage, take this DNA test so they will know if they are a carrier for sickle cell anemia.
- Learn about these diseases and make sure that your friends' children are also screened for this genetic disease.
- Bring this important subject up at family gatherings.
- Available February 10, 2008
Take this seriously. You have the power to prevent sickle cell anemia in our next generation...it all starts with you, your concern, and your willingness to learn and act.
For more information:
Sickle Cell / β-Thalassemia Panel
Sickle cell disease and β-thalassemia make up our hemoglobinopathies panel which are inherited disorders affecting the structure, function or production of globin genes, essential for the production of hemoglobin. Many mutations in the globin genes were detected, of which about 20 account for more than 90% of β-thalassemia and Sickle cell afflicted individuals worldwide. Our hemoglobinopathies panel contains them all and more. As it is not uncommon to have various globin mutations affecting the same individual we recommend to be tested for a routine hemoglobin electrophoresis by your health care provider and for both the Sickle cell and β-thalassemia mutations included in our panel.
Regular price: $149. Introductory price: $75
- /catalog/panel/productId/72
-
- $75.00